Trends and outcome of statin therapy in dialysis patients with atherosclerotic cardiovascular diseases: A population-based cohort study.

Trends and outcome of statin therapy in dialysis patients with atherosclerotic cardiovascular diseases: A population-based cohort study.

<h4>Background</h4>Although statins are an effective strategy for the secondary prevention of atherosclerotic cardiovascular disease (ASCVD) in the general population, the benefits for dialysis patients are controversial. We sought to assess trends of statin use and evaluate outcomes of...

Full description

Bibliographic Details
Main Authors:	Myunhee Lee, Yu Ah Hong, Jun-Pyo Myong, Kyusup Lee, Mahn-Won Park, Dae-Won Kim
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2023-01-01
Series:	PLoS ONE
Online Access:	https://doi.org/10.1371/journal.pone.0286670

Similar Items

Association between statin therapy and mortality in patients on dialysis after atherosclerotic cardiovascular diseases
by: Myunhee Lee, et al.
Published: (2023-07-01)

Evidence‐Based Optimal Medical Therapy and Mortality in Patients With Acute Myocardial Infarction After Percutaneous Coronary Intervention
by: Kyusup Lee, et al.
Published: (2023-05-01)

Do statins benefit low-risk population for primary prevention of atherosclerotic cardiovascular disease: A retrospective cohort study
by: In Sun Ryou, et al.
Published: (2022-11-01)

Strategic multimodal non‐invasive assessment of cardiac performance in patients with heart failure
by: Mi‐Jeong Kim, et al.
Published: (2023-08-01)

Landscape of Statin as a Cornerstone in Atherosclerotic Cardiovascular Disease
by: Cheng Yang, et al.
Published: (2023-12-01)

Clinical impact of statin intensity according to age in patients with acute myocardial infarction.
by: Kyusup Lee, et al.
Published: (2022-01-01)

Clinical impact of statin intensity according to age in patients with acute myocardial infarction
by: Kyusup Lee, et al.
Published: (2022-01-01)

The Risk of Atherosclerotic Cardiovascular Disease among Hyperlipidaemia Patients and Appropriateness of Statin Therapy
by: Maharani F. Iskandar, et al.
Published: (2018-04-01)

High‐Intensity Statin Reduces the Risk of Mortality Among Chronic Liver Disease Patients With Atherosclerotic Cardiovascular Disease: A Population‐Based Cohort Study
by: Sungho Bea, et al.
Published: (2023-04-01)

Global trends in atherosclerotic cardiovascular disease
by: Nedkoff, L, et al.
Published: (2023)

[Current statin use for patients with atherosclerotic cardiovascular disease in 39 large Chinese hospitals].
by: Zhang, D, et al.
Published: (2011)

Patterns and gaps in guideline-directed statin use for atherosclerotic cardiovascular disease by race and ethnicity
by: Ashish Sarraju, et al.
Published: (2024-03-01)

Beyond Statins: Novel Lipid-Lowering Agents for Reducing Risk of Atherosclerotic Cardiovascular Disease
by: Teimur Kayani, et al.
Published: (2024-03-01)

Clinical Outcome of Rotational Atherectomy in Calcified Lesions in Korea-ROCK Registry
by: Kyusup Lee, et al.
Published: (2021-07-01)

Anti-atherosclerotic vaccination against Porphyromonas gingivalis as a potential comparator of statin in mice
by: Hyun-Su Ha, et al.
Published: (2021-04-01)

Underuse of statins in patients with atherosclerotic ischemic stroke in China.
by: Li, X, et al.
Published: (2012)

Metabolic changes with the occurrence of atherosclerotic plaques and the effects of statins
by: Lingmin Zhao, et al.
Published: (2023-12-01)

Saturated fat intake, statin therapy and atherosclerotic vascular disease: A prospective cohort study
by: L. Blekkenhorst, et al.
Published: (2014-12-01)

Cholesterol-lowering statin therapy to prevent atherosclerotic cardiovascular disease - is the new guideline based on best evidence?
by: Canoy, D
Published: (2014)

Cholesterol-lowering statin therapy to prevent atherosclerotic cardiovascular disease - Is the new guideline based on best evidence?
by: Canoy, D
Published: (2014)

Machine learning reveals sex-specific associations between cardiovascular risk factors and incident atherosclerotic cardiovascular disease
by: Soongu Kwak, et al.
Published: (2023-06-01)

Risk assessment of atherosclerotic cardiovascular diseases before statin therapy initiation: Knowledge, attitude, and practice of physicians in Yemen.
by: Fahmi Y Al-Ashwal, et al.
Published: (2022-01-01)

Statin uses in adults with non-dialysis advanced chronic kidney disease: Focus on clinical outcomes of infectious and cardiovascular diseases
by: Ching-Chung Hsiao, et al.
Published: (2022-09-01)

Stair climbing and the incidence of atherosclerotic cardiovascular disease: a population-based prospective cohort study
by: Ahmed Arafa, et al.
Published: (2023-10-01)

Prediction of the 10-year risk of atherosclerotic cardiovascular disease in the Korean population
by: Sangwoo Park, et al.
Published: (2023-05-01)

The Effects of Statins Unrelated to Cholesterol level on Clinical Outcome of Continuous Ambulatory Peritoneal Dialysis Patients
by: Sug kyun Shin, et al.
Published: (2012-06-01)

Atherosclerotic cardiovascular disease thresholds for statin initiation among people living with HIV in Thailand: A cost-effectiveness analysis.
by: David C Boettiger, et al.
Published: (2021-01-01)

Study on the Efficacy Differences of Moderate-dose Statin Therapy in Patients with Atherosclerotic Cardiovascular Disease among Different Ethnic Groups
by: LUO Sifu, JIN Menglong, SUBINUER· Jureti, LIU Ziyang, FU Zhenyan
Published: (2024-12-01)

Statin Use and Eligibility for Primary Prevention of Atherosclerotic Cardiovascular Disease Among Adults at Borderline or Intermediate Risk in the United States
by: Michael M. Hammond, et al.
Published: (2023-04-01)

Clinical encounter length and initiation of statin therapy for primary prevention among adults with elevated atherosclerotic cardiovascular disease risk
by: Alexander R. Zheutlin, et al.
Published: (2023-03-01)

Impact of China’s Low Centralized Medicine Procurement Prices on the Cost-Effectiveness of Statins for the Primary Prevention of Atherosclerotic Cardiovascular Disease
by: Miao Wang, et al.
Published: (2020-06-01)

Achievement of low-density lipoprotein cholesterol targets in Chinese patients with atherosclerotic cardiovascular disease after receiving statins and ezetimibe
by: Yinchu Cheng, et al.
Published: (2022-10-01)

Effects of Race on Statin Prescribing for Primary Prevention With High Atherosclerotic Cardiovascular Disease Risk in a Large Healthcare System
by: Michael P. Dorsch, et al.
Published: (2019-11-01)

Using deep learning-based natural language processing to identify reasons for statin nonuse in patients with atherosclerotic cardiovascular disease
by: Ashish Sarraju, et al.
Published: (2022-07-01)

Population-wide cohort study of statin use for the secondary cardiovascular disease prevention in Scotland in 2009–2017
by: Thalmann, I, et al.
Published: (2022)

Inflammatory burden, lifestyle and atherosclerotic cardiovascular disease: insights from a population based cohort study
by: Benjamin Bay, et al.
Published: (2023-12-01)

Comparative Effectiveness of Long‐Term Maintenance Beta‐Blocker Therapy After Acute Myocardial Infarction in Stable, Optimally Treated Patients Undergoing Percutaneous Coronary Intervention
by: Myunhee Lee, et al.
Published: (2023-08-01)

Age‐Related Associations of Low‐Density Lipoprotein Cholesterol and Atherosclerotic Cardiovascular Disease: A Nationwide Population‐Based Cohort Study
by: Han Na Jung, et al.
Published: (2022-05-01)

Long-term statin adherence in patients after hospital discharge for new onset of atherosclerotic cardiovascular disease: a population-based study of real world prescriptions in Taiwan
by: Shu-ting Chen, et al.
Published: (2019-03-01)

Prescribing trends of glaucoma medication in Korea from 2007 to 2020: A nationwide population-based study.
by: Kyeong Ik Na, et al.
Published: (2024-01-01)